Monoclonal antibodies are novel therapeutic ... their efficacy and between the agents themselves. Antibodies against B cells Rituximab is a depleting antibody directed against CD20 on the surface ...
Monoclonal antibody design begins with identifying antibodies that bind to a specific target. One way to do this is to isolate antibody producing B-cells from human blood samples. Scientists then ...
A Golden Gate-based dual-expression vector enables rapid screening, which facilitates efficient isolation of high-affinity cross-reactive antibodies for therapeutic or diagnostic use and provides a ...
As cancer cells ... Chronic active antibody-mediated rejection (caAMR) is a common cause of allograft loss after transplantation, with no approved therapies. Clazakizumab, a monoclonal antibody ...
Fusion Antibodies PLC offers various antibody engineering services for all therapeutic ... Its services include antibody sequencing, antibody humanization, stable cell line development, monoclonal ...